* If you want to update the article please login/register
121 patients with DMD underwent a controlled, double-blind, placebo-, and prednisone-controlled trial of vamorolone. The trial included the primary and first four sequential motor function end points; vainolone showed bone morbidities in comparison to prednisone, with no stunting of growth nor any deleterious changes in bone biomarkers;.
Source link: https://zenodo.org/record/7064653
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions